Myeloma evades T cell-engaging therapies

Competing interests

B.P. reports consultancy fees from BMS, GSK, Janssen, Sanofi and Takeda; research funding from BMS, GSK, Roche and Sanofi; and honoraria from Adaptive, Amgen, Becton Dickinson, BMS-Celgene, GSK, Janssen, Sanofi and Roche. J.F.S.-M. reports consultancy fees from Abbvie, Amgen, BMS, Celgene, Roche, GSK, Janssen, Karyopharm, Merck, Novartis, Sanofi and Takeda.

留言 (0)

沒有登入
gif